Prospective observational study on cytokine removal in continuous hemodiafiltration

Prospective observational study on cytokine removal in continuous hemodiafiltration - Prospective observational study on cytokine removal in continuous hemodiafiltration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040565

Enrollment

150

Registered

2020-05-28

Start date

2020-02-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who started continuous hemodiafiltration

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with written or verbal consent

Exclusion criteria

Exclusion criteria: Patients who the investigator determined to be inappropriate as subjects (Patients who deviate from the dialysis conditions [dialysis fluid 0.4 L / hour, replacement fluid 0.4 L / hour], who also use endotoxin adsorption therapy, who need to change the purification membrane within 24 hours of CHDF start, and within 24 hours. Those who have completed CHDF)

Design outcomes

Primary

Measure	Time frame
Changes in various blood cytokine levels 2, 18 and 24 hours after the start of CHDF	—

Countries

Japan

Contacts

Public ContactJunichiro Nakata

Juntendo University Hospital Department of Nephrology

jnakata@juntendo.ac.jp03-3813-3111

Outcome results